Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Liabilities and Shareholders Equity (2023 - 2025)

Wellgistics Health filings provide 3 years of Liabilities and Shareholders Equity readings, the most recent being $30.5 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 46.87% to $30.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $195.5 million, a 241.04% increase, with the full-year FY2025 number at $30.5 million, down 46.87% from a year prior.
  • Liabilities and Shareholders Equity hit $30.5 million in Q4 2025 for Wellgistics Health, down from $52.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $58.1 million in Q1 2025 to a low of $338364.0 in Q4 2023.
  • Median Liabilities and Shareholders Equity over the past 3 years was $53.5 million (2025), compared with a mean of $42.2 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 16844.08% in 2024 and later crashed 46.87% in 2025.
  • Wellgistics Health's Liabilities and Shareholders Equity stood at $338364.0 in 2023, then soared by 16844.08% to $57.3 million in 2024, then plummeted by 46.87% to $30.5 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $30.5 million (Q4 2025), $52.8 million (Q3 2025), and $54.2 million (Q2 2025) per Business Quant data.